HCAN:PA:PA-HSBC MSCI Canada UCITS ETF (EUR)

ETF | Others |

Last Closing

USD 23.469

Change

0.00 (0.00)%

Market Cap

USD 0.03B

Volume

201.00

Analyst Target

N/A
Analyst Rating

Verdict

ducovest Verdict

Verdict

About

Unadjusted Closing Price

Adjusted Closing Price

Share Volume

Relative Performance (Total Returns)

Compare
Relative Returns (From:    To: 2024-12-28 )

Largest Industry Peers for Others

Symbol Name Price(Change) Market Cap
JPX4:PA Amundi Index Solutions - Amund..

-0.04 (-0.09%)

USD 61.38B
SPY5:PA SPDR® S&P 500 UCITS ETF EUR

+1.00 (+0.18%)

USD 13.43B
WRD:PA HSBC MSCI World UCITS ETF

+0.10 (+0.29%)

USD 11.05B
SP5C:PA Lyxor S&P 500 UCITS ETF - C-EU..

+0.71 (+0.17%)

USD 9.62B
EQQQ:PA Invesco EQQQ NASDAQ-100 UCITS ..

+1.05 (+0.21%)

USD 8.88B
MEUD:PA Amundi Stoxx Europe 600 UCITS ..

+2.65 (+1.12%)

USD 8.55B
HHH:PA HSBC S&P 500 UCITS ETF

+0.04 (+0.06%)

USD 7.68B
WLD:PA Lyxor UCITS MSCI World D-EUR

+0.71 (+0.20%)

USD 7.63B
LCWD:PA Multi Units Luxembourg - Lyxor..

+0.04 (+0.20%)

USD 6.83B
S500:PA Amundi S&P 500 ESG UCITS ETF A..

+0.24 (+0.15%)

USD 5.48B

ETFs Containing HCAN:PA

N/A

Market Performance

  Market Performance vs. Industry/Classification (Others) Market Performance vs. Exchange
  Value Sector Median Percentile Rank Grade Market Median Percentile Rank Grade
YTD  
Capital Gain 16.54% 64% D 75% C
Dividend Return 3.46% 69% C- 59% D-
Total Return 19.99% 69% C- 76% C+
Trailing 12 Months  
Capital Gain 16.54% 64% D 75% C
Dividend Return 3.46% 69% C- 59% D-
Total Return 19.99% 69% C- 76% C+
Trailing 5 Years  
Capital Gain 45.28% 67% D+ 75% C
Dividend Return 13.02% 56% F 50% F
Total Return 58.30% 72% C 77% C+
Average Annual (5 Year Horizon)  
Capital Gain 11.83% 68% D+ 68% D+
Dividend Return N/A 43% F 99% N/A
Total Return N/A 13% F 90% A-
Risk Return Profile  
Volatility (Standard Deviation) N/A 65% D 87% B+
Risk Adjusted Return N/A 26% F 95% A
Market Capitalization 0.03B 11% F 28% F

Annual Financials (EUR)

Quarterly Financials (EUR)

Analyst Rating

Target Price Action Rating Action Analyst Rating Price Date

This is a composite scorecard based on the application of evaluation criteria deemed most important by analysts. This is not a buy or sell recommendation.

What to like:

There is nothing we particularly like

What to not like:
Poor risk adjusted returns

This company is delivering below median risk adjusted returns in its peers. Even if it is outperforming on returns , the returns are unpredictable. Proceed with caution.

Below median dividend returns

The company’s average income yield over the past 5 years has been low compared to its peers. However, it is not a problem if you are not looking for income.

Below median total returns

The company has under performed its peers on annual average total returns in the past 5 years.

Low market capitalization

This is among the smaller entities in its sectors with below median market capitalization. That may make it less stable in the long run unless it has a unique technology or market which can help it grow or get acquired in future.